Yesterday, inspired by a post by fellow ScienceBlogger Martin, I had a little fun discussing the evolution of “alternative” medicine (a.k.a. “complementary and alternative medicine” or CAM), specifically speculating about the possible selective pressures, positive and negative, that have influenced the course that its evolution took. Essentially, the discussion centered around whether, by its very […]
Author: Orac
Orac is the nom de blog of a humble surgeon/scientist who has an ego just big enough to delude himself that someone, somewhere might actually give a rodent's posterior about his copious verbal meanderings, but just barely small enough to admit to himself that few probably will. That surgeon is otherwise known as David Gorski.
That this particular surgeon has chosen his nom de blog based on a rather cranky and arrogant computer shaped like a clear box of blinking lights that he originally encountered when he became a fan of a 35 year old British SF television show whose special effects were renowned for their BBC/Doctor Who-style low budget look, but whose stories nonetheless resulted in some of the best, most innovative science fiction ever televised, should tell you nearly all that you need to know about Orac. (That, and the length of the preceding sentence.)
DISCLAIMER:: The various written meanderings here are the opinions of Orac and Orac alone, written on his own time. They should never be construed as representing the opinions of any other person or entity, especially Orac's cancer center, department of surgery, medical school, or university. Also note that Orac is nonpartisan; he is more than willing to criticize the statements of anyone, regardless of of political leanings, if that anyone advocates pseudoscience or quackery. Finally, medical commentary is not to be construed in any way as medical advice.
To contact Orac: [email protected]
Abel Pharmboy at Terra Sigillata has the full story. In brief, Medicare has slashed reimbursement for two radioimmunotherapy drugs Bexxar (131I-tositumomab) and Zevalin (90Y-ibritumomab) to below acquisition cost. This is not some experimental therapy that’s being denied, but rather a therapy with a established clinical efficacy. Naturally, this is likely to lead to most centers […]
I wish I had thought of this one, but I didn’t. However, I never let a little thing like not having thought of an idea first to stop me from discussing it, and this particular idea is definitely worth expanding upon because (1) it’s interesting and (2) it combines two of my interests, alternative medicine […]
Friday morning while doing some work in my office, I was treated to a discussion by the two hosts of a morning radio talk show. The talk was apparently prompted by a rather odd website, ihateyoungpeople.com, which asks: We want you to create a video of yourself explaining what you hate the most about young […]
Hilarious. Even though I risk bringing back some of the anthropogenic global warming “skeptics” (in reality pseudoskeptics) here, this is too rich not to mention, because it reminds me of how advocates of all stripes of pseudoscience react, particularly advocates of alternative medicine, most of whom wouldn’t recognize a well-designed study if it bit them […]
